Trademarkia Logo

About 19 Trademarks found for “PINK TABLET DESIGN”

Filters

Also try searching for:

PINK TABLET DESIGN*

PINK*

*IGN

PI*GN

1092908
WITHDRAWN BY OWNER

on 7 Jan 2005

PINK TABLET DESIGN

ASTRAZENECA AB

1092908 · 15 Feb 2001

005

Pharmaceutical tablets containing esomeprazole.

1051847
WITHDRAWN BY OWNER

on 4 Nov 2004

TABLET DESIGN (PINK)

BRISTOL-MYERS SQUIBB COMPANY

1051847 · 22 Mar 2000

005

Pharmaceutical preparations, namely a cholesterol lowering agent, cont...

819695
WITHDRAWN BY OWNER

on 21 Jun 2005

PINK TABLET DESIGN

PFIZER CANADA INC.

819695 · 2 Aug 1996

005

Pharmaceutical preparations and substances containing ranitidine or ra...

815155
WITHDRAWN BY OWNER

on 17 Nov 2003

PINK TABLET DESIGN

ASTRAZENECA AB

815155 · 12 Jun 1996

005

Pharmaceutical tablets containing omeprazole magnesium for use in the ...

719245
WITHDRAWN BY OWNER

on 27 Apr 1999

TABLET PINK DESIGN

PFIZER CANADA INC.

719245 · 24 Dec 1992

005

Pharmaceutical preparation, namely, an antifungal preparation containi...

699917
ABANDONED SECTION 40(3)

on 26 Apr 2005

TABLET DESIGN (PINK)

ASTRAZENECA AB

699917 · 28 Feb 1992

005

Pharmaceutical preparations, namely, felodipine.

671135
REFUSED

on 15 Sept 1997

TABLET DESIGN (PINK)

HOECHST AKTIENGESELLSCHAFT

671135 · 27 Nov 1990

005

Pharmaceutical preparations, namely pentoxifylline.

630536
REFUSED IN ACCORDANCE WITH TRADEMARKS OPPOSITION BOARD DECISION

on 2 Jun 2004

TABLET DESIGN (PINK)

NOVARTIS PHARMACEUTICALS CANADA INC.

630536 · 25 Apr 1989

005

Pharmaceutical preparations, namely diclofenac sodium.

630537
REFUSED IN ACCORDANCE WITH TRADEMARKS OPPOSITION BOARD DECISION

on 2 Jun 2004

TABLET DESIGN (PINK)

NOVARTIS PHARMACEUTICALS CANADA INC.

630537 · 25 Apr 1989

005

Pharmaceutical preparations, namely diclofenac sodium.

1113662
WITHDRAWN BY OWNER

on 6 Oct 2005

TRIANGULAR PINK TABLET DESIGN

GLAXO GROUP LIMITED

1113662 · 23 Aug 2001

005

Pharmaceutical preparations and substances containing sumatriptan for ...

Owners

Reckitt benckiser n.V. (5)

Astrazeneca ab (4)

Glaxo group limited (3)

Bristol-myers squibb company (2)

Novartis pharmaceuticals canada inc. (2)

Pfizer canada inc. (2)

Hoechst aktiengesellschaft (1)

Categories

Class 5 (14)

Class 1 (5)

Class 3 (5)

Class 11 (5)

Class 21 (5)

Correspondents

Smart & biggar lp (7)

Gowling wlg (canada) llp (2)

Marks & clerk (1)

Page 1 of 2